ArticleMolecular cancer2012

In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survival.

Kyle J Thulien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.